DEC 26, 2018 8:13 PM PST

When the Immune System Makes a Mistake: Autoimmunity

WRITTEN BY: Nicholas Breehl

A team from Scripps Research has found a molecular cause of a group of rare autoimmune disorders in which the immune system attacks the body's healthy cells.


The discovery, published Dec. 18 in Nature Communications, improves understanding of a protein's role in several autoimmune disorders, including Singleton-Merten syndrome (SMS), Aicardi-Goutières syndrome, familial chilblain lupus, proteasome-associated autoinflammatory syndromes and many others which involve improper stimulation of interferon, says Patrick Griffin, PhD, professor and co-chair of the Department of Molecular Medicine at Scripps Research's Florida campus.


Interferon is a critical component of our frontline defense against pathogens. Interferon earned its name because it interferes with virus' ability to make copies of themselves. The immune system relies on a gene called RIG-I, short for retinoic acid-inducible gene-I, to signal for the release of interferon whenever specific viral markers are encountered. RIG-I has to determine if the markers are of foreign origin or are from its own body. The scientists demonstrated precisely how mistakes in a molecular proofreading system could lead to confusion and generate out-of-control interferon signaling, setting off development of autoimmune disease.


"This dysregulated molecular mechanism of RIG-I mediated RNA proofreading that we identified may help us understand and treat SMS and other autoimmune disorders," says Jie Zheng, Ph.D., a postdoctoral associate and the first author and co-corresponding author of the study.


The National Institutes of Health estimates more than 20 million Americans suffer from autoimmune disorders. They include rheumatoid arthritis, psoriasis, inflammatory bowel disease, multiple sclerosis, lupus, type 1 diabetes, and dozens of others. There are very few safe and effective treatments for such disorders, mainly because so little is understood about how they arise and are sustained.


That is true for SMS, which is so rare that only a few cases have been described in the medical literature. Patients develop serious bone, heart, muscle and skin problems starting in early childhood, primarily due to chronic inflammation from an overactive immune system. The scientists aimed to understand how two RIG-I mutations linked to SMS end up triggering the autoimmunity.


Most viruses have genes made of ribonucleic acid, or RNA, a close chemical cousin of DNA. RIG-I works as an early-warning detector of viral RNA, capable of triggering a broad antiviral immune response, including interferon release. The scientists showed that mutations in RIG-I cause the sensor protein to activate even when it encounters non-viral, "self" RNA. The study aimed to discover the molecular details of how this happens.


RIG-I is a significant protein with flexible elements, and thus is hard to study with standard techniques. But Griffin has helped pioneer the use of an advanced technology called hydrogen-deuterium exchange mass spectrometry (HDX-MS), which enables scientists to analyze the structures and dynamics of just such proteins. For the study, he and his team applied HDX-MS to normal and mutant RIG-I and permanently solved the mystery of how these mutations cause a failure of discrimination between self and viral RNA.


Scientists have known that RIG-I has a particular segment that it keeps mostly covered and concealed. When RIG-I encounters and recognizes viral RNA, this segment is supposed to briefly swing open and thus become available for binding to another protein called MAVS, an event that triggers the immune response. Griffin and colleagues found that the two SMS-linked mutations, in subtly different ways, cause this critical segment of RIG-I to become stuck open -- making it much more likely to bind to MAVS and trigger an immune response.


The scientists now are using their data to try to find a way to target mutant RIG-I, to block its inappropriate signaling to MAVS and thus alleviate the autoimmunity it causes.


This new, detailed understanding of RIG-I's dysfunction may not only provide insights into the origins of more common autoimmune disorders, Griffin says, but it also clarifies how RIG-I usually works to detect viruses, a discovery that may enable development of new antiviral drugs.

Sources: Science Daily, Nature Communications, YouTube

About the Author
You May Also Like
FEB 02, 2021
Immunology
Tumors Under Seige by Cancer-Killing Salmonella
FEB 02, 2021
Tumors Under Seige by Cancer-Killing Salmonella
Salmonella is a genus of rod-shaped bacteria, often given a bad rap thanks to its association with food poisoning. But c ...
MAR 22, 2021
Cell & Molecular Biology
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
MAR 22, 2021
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
Immunotherapy aims to make a patient's immune cells better at fighting cancer. The immune system has to be used carefull ...
APR 08, 2021
Immunology
It's Not Just Cholesterol That Clogs Arteries
APR 08, 2021
It's Not Just Cholesterol That Clogs Arteries
Researchers have discovered a gene that is directly linked to the development of cardiovascular diseases, such as high b ...
MAY 17, 2021
Cell & Molecular Biology
Survey Results: Where Is Pluripotent Stem Cell Research Now?
MAY 17, 2021
Survey Results: Where Is Pluripotent Stem Cell Research Now?
Human pluripotent stem cell (hPSC) lines are now commonly used across the globe. In the lab, researchers rely on hPSCs t ...
MAY 11, 2021
Genetics & Genomics
Gene Therapy Trial for Severe Immune Disorder is Successful
MAY 11, 2021
Gene Therapy Trial for Severe Immune Disorder is Successful
Severe combined immunodeficiency (SCID), which virtually eliminates a patient's immune system, and severely affects thei ...
MAY 31, 2021
Immunology
Engineering Faster, More Agile T Cell Cancer Fighters
MAY 31, 2021
Engineering Faster, More Agile T Cell Cancer Fighters
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...
Loading Comments...